《大行報告》大摩升特斯拉(TSLA.US)目標價至1,200美元 料未來12個月能證明製造領先地位
摩根士丹利近日發表報告表示,特斯拉(TSLA.US)藉成本及產品複雜性的逐步變化以及汽車用戶羣的更高增長,料其未來12個月能夠證明其行業製造的領先地位。
該行重申對特斯拉「增持」評級,對其目標價由900美元上調至1,200美元,此相當預測2030年企業價值對EBITDA的14倍。
大摩表示,上調對特斯拉目標偠價主要是預期銷售表現更高,估計公司至2030年銷售達810萬輛,即年均增長率28%(原本預測580萬輛,年均增長23%)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.